Minerva Neurosciences, Inc. (NERV)
NASDAQ: NERV · Real-Time Price · USD
4.700
+0.080 (1.73%)
Jul 9, 2026, 2:01 PM EDT - Market open
Minerva Neurosciences Market Cap
Minerva Neurosciences has a market cap or net worth of $218.97 million as of July 9, 2026. Its market cap has increased by 1,637.83% in one year.
Market Cap
218.97M
Enterprise Value
197.17M
1-Year Change
1,637.83%
Ranking
Category
Stock Price
$4.70
Market Cap Chart
Since July 1, 2014, Minerva Neurosciences's market cap has increased from $110.60M to $218.97M, an increase of 97.98%. That is a compound annual growth rate of 5.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 218.97M | 679.24% |
| Dec 31, 2025 | 28.10M | 81.29% |
| Dec 31, 2024 | 15.50M | -63.95% |
| Dec 29, 2023 | 43.00M | 405.88% |
| Dec 30, 2022 | 8.50M | -75.15% |
| Dec 31, 2021 | 34.20M | -65.77% |
| Dec 31, 2020 | 99.90M | -64.00% |
| Dec 31, 2019 | 277.50M | 5.92% |
| Dec 31, 2018 | 262.00M | 11.92% |
| Dec 29, 2017 | 234.10M | -42.76% |
| Dec 30, 2016 | 409.00M | 172.49% |
| Dec 31, 2015 | 150.10M | 35.23% |
| Dec 31, 2014 | 111.00M | 0.36% |
| Jul 1, 2014 | 110.60M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Keros Therapeutics | 230.57M |
| Camp4 Therapeutics | 228.47M |
| Voyager Therapeutics | 228.39M |
| Karyopharm Therapeutics | 227.76M |
| Atrium Therapeutics | 226.48M |
| Cellectis | 226.33M |
| Compugen | 226.06M |
| Whitehawk Therapeutics | 223.20M |